Characterization of emeA, a norA homolog and multidrug resistance efflux pump, in Enterococcus faecalis

被引：90
|
作者：
Jonas, BM
Murray, BE
Weinstock, GM
机构：
[1] Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Ctr Study Emerging & Reemerging Pathogens, Houston, TX 77030 USA
[3] Univ Texas, Sch Med, Div Infect Dis, Houston, TX 77030 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 12期
关键词：
D O I：
10.1128/AAC.45.12.3574-3579.2001
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We hypothesized that multidrug resistance efflux pumps (MDRs) may be contributing to the drug resistance of enterococci. We recently identified potential MDR-encoding genes in the Enterococcus faecalis V583 genome. Among the putative MDRs, we found a gene that encodes a NorA homolog and have characterized this enterococcal MDR in the present study. A mutant from which the enterococcal NorA homolog has been deleted has reduced resistance to several NorA substrates. Complementation of the deletion mutant with the wild-type gene verified the involvement of this enterococcal gene in resistance to ethidium bromide (EtBr) and norfloxacin. Known MDR inhibitors (reserpine, lansoprazole, and verapamil) inhibit the efflux of EtBr and norfloxacin in wild-type strain OG1RF. A fluorescence assay with EtBr allowed us to quantitate the efflux capability of the enterococcal NorA pump. On the basis of these results, we have named this enterococcal gene emeA (enterococcal multidrug resistance efflux).
引用
收藏
页码：3574 / 3579
页数：6
相关论文
共 50 条
  • [31] Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori
    Zhan Zhang
    World Journal of Gastroenterology, 2010, 16 (10) : 1279 - 1284
  • [32] The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus
    Price, CTD
    Kaatz, GW
    Gustafson, JE
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (03) : 206 - 213
  • [33] Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor
    Adabi, Maryam
    Talebi-Taher, Mahshid
    Arbabi, Leila
    Afshar, Mastaneh
    Fathizadeh, Sara
    Minaeian, Sara
    Moghadam-Maragheh, Niloufar
    Majidpour, Ali
    INFECTION AND CHEMOTHERAPY, 2015, 47 (02): : 98 - 104
  • [34] Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa
    Kriengkauykiat, J
    Porter, E
    Lomovskaya, O
    Wong-Beringer, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 565 - 570
  • [35] Clinically Approved Drugs Inhibit the Staphylococcus aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation
    Zimmermann, Saskia
    Klinger-Strobel, Mareike
    Bohnert, Juergen A.
    Wendler, Sindy
    Roedel, Juergen
    Pletz, Mathias W.
    Loeffler, Bettina
    Tuchscherr, Lorena
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [36] Role of EfrAB efflux pump in biocide tolerance and antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from traditional fermented foods and the effect of EDTA as EfrAB inhibitor
    Lavilla Lerma, Leyre
    Benomar, Nabil
    Sanchez Valenzuela, Antonio
    Casado Munoz, Maria del Carmen
    Galvez, Antonio
    Abriouel, Hikmate
    FOOD MICROBIOLOGY, 2014, 44 : 249 - 257
  • [37] Synthesis and Characterization of Piperine Analogs as Potent Staphylococcus aureus NorA Efflux Pump Inhibitors
    Chopra, Bhawna
    Dhingra, Ashwani K.
    Dhar, K. L.
    CHEMICAL METHODOLOGIES, 2019, 3 (01): : 104 - 114
  • [38] Efflux Pump Contribution to Multidrug Resistance in Clinical Isolates of Pseudomonas aeruginosa
    Kiser, Tyree H.
    Obritsch, Marilee D.
    Jung, Rose
    MacLaren, Robert
    Fish, Douglas N.
    PHARMACOTHERAPY, 2010, 30 (07): : 632 - 638
  • [39] Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer
    Modok, Szabolcs
    Mellor, Howard R.
    Callaghan, Richard
    CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (04) : 350 - 354
  • [40] TbtABM, a multidrug efflux pump associated with tributyltin resistance in Pseudomonas stutzeri
    Jude, F
    Arpin, C
    Brachet-Castang, C
    Capdepuy, M
    Caumette, P
    Quentin, C
    FEMS MICROBIOLOGY LETTERS, 2004, 232 (01) : 7 - 14
12345